But don't just take our word for it
At the 52-week mark, average weight loss was 19.5% of total body weight
If youve been following the news around medications like semaglutide (Ozempic, Wegovy) , tirzepatide (Mounjaro, Zepbound) , and the newer retatrutide (still in clinical trials) , youve probably heard about their impressive results
Treatment focuses on alleviating pain and managing symptoms, aiming to improve quality of life.12 This study aims to support the development of an evidence-based treatment protocol while emphasizing the urgent need for further research to enhance understanding and management of this complex condition
-As GLP-1 medications continue to expand for diabetes, obesity, and cardiometabolic health, clarifying the risk of rare but serious events like NAION is essential for clinicians, policymakers, and patients